Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
887.30
-16.25 (-1.80%)
< Home < Back

Natco Pharma informs about press release

Date: 24-11-2016

Natco Pharma has informed about a Press Release dated November 24, 2016 titled ‘Natco Receives Final approval for generic Budesonide Capsules, 3 mg, for USA market’.

The above information is a part of company’s filings submitted to BSE.